
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations Inc. demonstrated impressive performance in the second quarter of 2025, with total revenue reaching $11.8 million, representing a significant 58% year-over-year increase and exceeding estimates by $1.8 million. The company's robust growth strategy is underscored by stronger-than-expected average selling prices (ASPs) and a proactive approach in increasing the number of surgeons using its advanced shoulder implant systems, anticipated to grow at approximately 11 new surgeons per quarter moving forward. With an enhanced balance sheet and substantial market potential, Shoulder Innovations is well-positioned to continue expanding its commercial operations and achieve strong top-line growth in the coming years.
Bears say
Shoulder Innovations Inc. is facing significant financial challenges, evidenced by an adjusted EBITDA loss of $7.5 million, which exceeded previous projections by approximately $400,000. Contributing factors to a negative outlook include slower product adoption among new surgeons, anticipated lower market growth rates for shoulder surgeries, and a concerning increase in operating expenses, which were approximately $900,000 higher than modeled. Furthermore, the company is at risk of reduced average selling prices (ASP) and delayed entry into new market segments, further exacerbating its financial difficulties.
This aggregate rating is based on analysts' research of Shoulder Innovations LLC and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares